1. Home
  2. NLSP vs IMCC Comparison

NLSP vs IMCC Comparison

Compare NLSP & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • IMCC
  • Stock Information
  • Founded
  • NLSP 2015
  • IMCC 1980
  • Country
  • NLSP Switzerland
  • IMCC Israel
  • Employees
  • NLSP N/A
  • IMCC N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • NLSP Health Care
  • IMCC Health Care
  • Exchange
  • NLSP Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • NLSP 8.2M
  • IMCC 8.0M
  • IPO Year
  • NLSP 2021
  • IMCC N/A
  • Fundamental
  • Price
  • NLSP $0.19
  • IMCC $2.25
  • Analyst Decision
  • NLSP Hold
  • IMCC
  • Analyst Count
  • NLSP 1
  • IMCC 0
  • Target Price
  • NLSP N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • NLSP 11.0M
  • IMCC 28.1K
  • Earning Date
  • NLSP 07-30-2024
  • IMCC 08-12-2024
  • Dividend Yield
  • NLSP N/A
  • IMCC N/A
  • EPS Growth
  • NLSP N/A
  • IMCC N/A
  • EPS
  • NLSP N/A
  • IMCC N/A
  • Revenue
  • NLSP N/A
  • IMCC $53,886,735.00
  • Revenue This Year
  • NLSP N/A
  • IMCC $11.51
  • Revenue Next Year
  • NLSP N/A
  • IMCC $19.17
  • P/E Ratio
  • NLSP N/A
  • IMCC N/A
  • Revenue Growth
  • NLSP N/A
  • IMCC 12.87
  • 52 Week Low
  • NLSP $0.11
  • IMCC $1.13
  • 52 Week High
  • NLSP $1.21
  • IMCC $8.10
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 49.01
  • IMCC 39.76
  • Support Level
  • NLSP $0.19
  • IMCC $1.80
  • Resistance Level
  • NLSP $0.24
  • IMCC $2.98
  • Average True Range (ATR)
  • NLSP 0.03
  • IMCC 0.32
  • MACD
  • NLSP -0.00
  • IMCC 0.02
  • Stochastic Oscillator
  • NLSP 15.85
  • IMCC 38.17

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: